Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Safety and Efficacy of S53P4 Bioactive Glass Putty in Spinal Fusion Surgery: Post Market Clinical Follow-up Study

NCT05001893 is registered in ClinicalTrials.gov with Bonalive Biomaterials Ltd as lead sponsor.

NCT NCT05001893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05001893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Safety and Efficacy of S53P4 Bioactive Glass Putty in Spinal Fusion Surgery: Post Market Clinical Follow-up Study
Lead sponsor
Bonalive Biomaterials Ltd
Phase
Observational
Overall status
Unknown status
Start date
May 3, 2021
Completion date
December 31, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal deformity, spine fusion